Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CGA-Guided RT and Sintilimab in Elderly/Frail mCRC
NCT06665087Phase 2Not yet recruiting
- Sponsor
- Fudan University
- Start
- Nov 2024
- Primary completion
- Nov 2027
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of sintilimab in metastatic colorectal cancer (mCRC), sponsored by Fudan University. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
sintilimab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT06665087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06665087.